SOLUTION / PUBLIC SOURCE RECORD

CalproSmart remote monitoring for IBD patients

Source modified 23 Mar 2026·1 min read

From the public capture. Detailed factual notes from Business Norway. Statements and figures reflect the source at the time of capture.

  • Published 4 December 2025; updated 23 March 2026; 2-minute read. CalproSmart is described as a CE/IVD-approved home self-test for quantitative calprotectin measurement in stool samples. A smartphone app reads the result and sends it to a GDPR-compliant portal, which can integrate with hospital information systems and patient-reported outcome tools. Calprotectin is used as a biomarker for intestinal inflammation.
  • The page says remote measurement can help clinicians detect IBD flares earlier, reduce clinic visits and invasive procedures, and support longitudinal monitoring, including for children. It presents the approach as easing pressure on specialist departments and reducing travel-related emissions. Availability is listed for Europe and countries accepting CE/IVD; a research-use-only version is globally available. It cites examples of studies and a Czech clinic testimonial. Linked UN SDGs: 3 and 9.
  • Public contact: Ingvild Haukø, VP Market Development, mail@calpro.no. Company: CALPRO AS, Arnstein Arnebergs vei 30, 1366 Lysaker, Norway; calpro.no. No public phone, events or participation fees are shown.
+END OF CAPTURED RECORDContinue at the original source
STAY CURIOUS. LOOK NORTH.

Good ideas travel.

Explore the collection
SEARCH BUSINESS NORWAY
Search full research reports, companies, technologies and ideas.